Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease

Journal of the American Society of Nephrology

Volumn 6, Issue 6, 1995, Pages 1634-1642

  Choukroun, Gabriel ^a   Itakura, Yoshiyuki ^a   Albouze, Ginette ^a   Christophe, Jean Louis ^a   Man, Nguyen K ^a   Grünfeld, Jean Pierre ^a   Jungers, Paul ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Blood pressure; Chronic renal failure; Dietary protein intake; Gender; Polycystic kidney disease

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; DISEASE COURSE; FEMALE; HUMAN; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN INTAKE;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; BLOOD PRESSURE; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY FAILURE; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 0029552915     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. The European Polycystic Kidney Disease Consortium: The polycystic kidney disease 1 gene encodes a 14 kD transcript and lies within a duplicated region on chromosome 16. Cell 1994;77:881-894.
2. Reeders ST, Breuning MH, Davies KE, et al.: A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature 1985;317:542-544.
3. Peters DJM, Spruit L, Saris JJ, et al.: Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease. Nat Genet 1993;5:359-362.
4. Churchill DN, Bear JC, Morgan J, Payne RH, McManamon PJ, Gault MH: Prognosis of adult onset polycystic kidney disease re-evaluated. Kidney Int 1984;26:190-193.
5. Delaney VB, Adler S, Bruns FJ, Licinia M, Segel DP, Fraley DS: Autosomal dominant polycystic kidney disease: Presentation, complications and prognosis. Am J Kidney Dis 1985:104-111.
6. Parfrey PS, Bear JC, Morgan J, et al.: The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med 1990;323:1085-1090.
7. Franz KA, Reubi FC: Rate of functional deterioration in polycystic kidney disease. Kidney Int 1983;23:526-529.
8. Dalgaard OZ: Bilateral polycystic disease of the kidneys: A follow-up of two hundred and eighty-four patients and their families. Acta Med Scand Suppl 1957;158:326-347.
9. Pochet JM, Albouze G, Bobrie G, Landais P, Ferran C, Grünfeld JP: The natural history of inherited renal diseases. Contrib Nephrol 1989;75:100-107.
10. Roscoe JM, Brissenden JE, Williams A, Chery AL, Silverman M: Autosomal dominant polycystic kidney disease in Toronto. Kidney Int 1993;44: 1101-1108.
11. Ravine D, Walker RG, Gibson RN, et al.: Phenotype and genotype heterogeneity in autosomal dominant polycystic kidney disease. Lancet 1992;340:1330-1333.
12. Wright GD, Hughes AE, Larkin KA, Doherty CC, Nevin NC: Genetic linkage analysis, clinical features and prognosis of autosomal dominant polycystic kidney disease in Northern Ireland. Q J Med 1993;86:459-463.
13. Brook-Carter PJ, Peral B, Ward CJ, et al.: Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease - A contignous gene syndrome. Nat Genet 1994;8:328-332.
14. Zeier M, Geberth S, Stier E, Ritz E: Is family history of primary hypertension a determinant for renal prognosis in autosomal dominant polycystic kidney disease (ADPKD). J Am Soc Nephrol 1993;4:269.
15. Harrap SB, Davies DL, Macnicol AM, et al.: Renal, cardiovascular and hormonal characteristics of youg adults with autosomal dominant polycystic kidney disease. Kidney Int 1991;40:501-508.
16. Chapman AB, Johnson A, Gabow PA, Schrier RW: The renin-angiotensin- aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med 1990; 323:1091-1096.
17. Bell PE, Hossack KF, Gabow PA, Durr JA, Johnson AM, Schrier RW: Hypertension in autosomal dominant polycystic kidney disease. Kidney Int 1988;34:683-690.
18. Torres VE, Donnovan KA, Scili G, et al.: Synthesis of renin by tubulocystic epithelium in autosomal dominant polycystic kidney disease. Kidney Int 1992;42:364-373.
19. Graham PC, Lindrop GBM: The anatomy of the renin-secreting cell in adult polycystic kidney disease. Kidney Int 1988;33:1084-1090.
20. Torres VE, Wilson DM, Burnett JCJ, Johnson CM, Offord KP: Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease. Mayo Clin Proc 1991;66:1010-1017.
21. Watson ML, Macnicol AM, Allan PL, Wright AF: Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease. Kidney Int 1992;41:206-210.
22. Gabow P: Autosomal dominant polycystic kidney disease. N Engl J Med 1993;329:332-342.
23. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid Smith P, Danks DM: Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994;343:824-827.
24. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
25. De Santo NG, Coppola S, Anastasio P: Predicted creatinine clearance to assess glomerular filtration rate in chronic renal disease in humans. Am J Nephrol 1991; 11:181-185.
26. Rossing P, Astrup AS, Smidt UM, Pairing HH: Monitoring kidney function in diabetic nephropathy. Diabetologia 1994;37:708-712.
27. Maroni BJ, Steinman TI, Mitch WE: A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 1985;27:58-65.
28. Grünfeld JP, Albouze G, Jungers P, et al.: Liver changes and complications in adult polycystic kidney disease. Adv Nephrol 1985;14:1-18.
29. Pirson Y, Grünfeld JP. Autosomal dominant polycystic kidney disease. In: Cameron JS, Davison AM, Grünfeld JP, Kerr D, Ritz E, Eds. Oxford Textbook of Clinical Nephrology. Vol. 3. Oxford: Oxford University Press; 1992:2171-2188.
30. Jungers P, Albouze G, Aime F, et al. Problèmes posés par l'hémodialyse périodique et la transplantation rénale chez les malades atteints de maladie polykystique rénale. In: Küss R, Legrain M, Eds. Séminaires d'UroNéphrologie - Pitié-Salpétrière. Vol. 9. Paris: Masson; 1983:12-37.
31. Geberth S, Zweier H, Wiesel M, Gonzalo A, Waldherr R, Ritz E: Secular trend of renal survival in autosomal dominant polycystic kidney disease (ADPKD). Am J Kidney Dis 1993;22:A5.
32. Zeier M, Ritz E, Geberth S, Gonzalo A: Genesis and significance of hypertension in autosomal dominant polycytic kidney disease. Nephron 1994;68:155-158.
33. Gabow PA, Johnson AM, Kaehny WD, et al.: Factors affecting the progression of renal disease in autosomal dominant polycystic kidney disease. Kidney Int 1992;41: 1311-1319.
34. Bear JC, Parfrey PS, Morgan JM, Martin CJ, Cramer BC: Autosomal dominant polycystic kidney disease: New information for genetic counselling. Am J Med Genet 1992; 43:548-553.
35. Gretz N, Zeier M, Geberth S, Strauch M, Ritz E: Is gender a determinant for evolution of renal failure? A study in autosomal dominant polycystic kidney disease Am J Kidney Dis 1989;14:178-183.
36. Stewart JH: End-stage renal failure appears earlier in men than women with polycystic kidney disease. Am J Kidney Dis 1994;24:181-188.
37. Abdelrhamane M, Jeunemaitre X, Plouin PF, Chatelier G, Tugayé A: Créatininémie dans la polykystose rénale compliquée d'hypertension artérielle. Rôle du contrôle de la pression artérielle. Presse Med 1990;19:1801-1804.
38. Klahr S, Breyer JA, Beck GJ, et al.: Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. J Am Soc Nephrol 1995;5: 2037-2047.
39. Tomobe K, Philbrick D, Aukema HM, et al.: Early dietary protein restriction slows disease progression and lengthens survival in mice with polycystic kidney disease. J Am Soc Nephrol 1994;5:1355-1360.
40. Klahr S, Levey AS, Beck GJ, et al.: The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 1994;330:877-884.
41. Gonzalo A, Gallelo A, Rivera M, Orte L, Ortuño J: Shape of the relationship between hypertension and the rate of progression of renal failure in autosomal dominant polycystic kidney disease. Nephron 1992;62:52-57.
42. Hannedouche T, Landais P, Goldfarb B, et al.: Randomised controlled trial of enalapril and β blockers in non-diabetic chronic renal failure. Br Med J 1994;309:833-837.
43. Williams PS, Fass G, Bone JM: Renal pathology and proteinuria determine progression in untreated mild/ moderate chronic renal failure. Q J Med 1988;67:343-354.
44. Stenwinkel P, Alverstrand A, Bergström J: Factors influencing progression in patients with chronic renal failure. J Intern Med 1989;226:183-188.
45. Jungers P, Hannedouche T, Itakura Y, Albouze G, Descamps Latscha B, Man NK: Factors influencing the rate of progression from early to end-stage renal failure in non-diabetic renal disease. Nephrol Dial Transplant (in press).
46. Zeier M, Fehrenbach P, Geberth S, Möhring K, Waldher R, Ritz E: Renal histology in polycystic kidney disease with incipient and advanced renal failure. Kidney Int 1992;42:1259-1265.
47. Chapman AB, Johnson AM, Gabow PA, Schrier RW: Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1994;5:1349-1354.
48. Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation and intrinsic renal disease. N Engl J Med 1982;307:652-659.